India  

Brazilian regulator says Covaxin manufacturing facility fails to meet CGMP standards

Hindu Wednesday, 31 March 2021
Bharat Biotech said it is working towards resolving the issues cited during the inspection and the order of 20 million doses from the Brazilian government is still active
0
shares
ShareTweetSavePostSend
 

You Might Like